Edward J. Licitra, MD, PhD, Board Chairperson

Dr. Edward J. Licitra is board certified in internal medicine and medical oncology. For more than 7 years, he has been treating patients in the central New Jersey community.
Dr. Licitra received his PhD from the Massachusetts Institute of Technology. He received his medical degree from the University of Medicine and Dentistry of New Jersey — Robert Wood Johnson Medical School, where he served his residency in internal medicine.

Terrill Jordan, President & CEO

Terrill Jordan is President and Chief Executive Officer at Regional Cancer Care Associates.  Under his leadership, RCCA is driving to become a national leader in high-quality, value-based community oncology care.

Seth H. Berk, MD

Dr. Seth Howard Berk specializes in hematology and medical oncology and is board certified in internal medicine, hematology and oncology. For more than 13 years, he has been treating patients in the Mount Holly community. Dr. Berk is Section Chief of hematology/oncology at Virtua Memorial Hospital, Assistant Chairman of the Department of Medicine, and Co-Chairman of the Internal Medicine Physician Peer Review Committee. He is actively involved in enrolling patients in clinical trials.

Joel Silver, MD

Dr. Joel Silver specializes in medical oncology and is board certified. He received his medical degree from Thomas Jefferson University School of Medicine and completed his internal medicine residency as well as his fellowship at University of Connecticut.

Michael Reale, MD

Dr. Michael Reale specializes in medical oncology and is board certified. He received his medical degree from Mount Sinai School of Medicine and completed his internal medicine residency at Beth Israel Hospital and his fellowship at Yale School of Medicine.

Dongmei Wang, MD

Dr. Dongmei Wang is a board certified medical oncology specialist. She received her medical degree from Capital University of Medical Sciences in Beijing and completed her internal medicine residency at St. Vincent’s Medical Center in Bridgeport, CT and her oncology/hematology fellowship at the National Cancer Institute in Bethesda, MD.

Paul Bannen, MD

Dr. Paul Bannen specializes in medical oncology and is board certified. He received his medical degree from University Of Missouri-Columbia School of Medicine and completed his internal medicine residency at University of Texas Health Science Center.

Frederick P. Smith, MD

Frederick P. Smith, M.D., is a board-certified medical oncologist who completed his oncology training at Georgetown University’s Lombardi Cancer Center.

Ralph V. Boccia, MD

Dr. Boccia specializes in hematology and medical oncology and is board certified in both. He completed his medical school at the University of Minnesota and completed training in internal medicine at University of California, Los Angeles (UCLA)–affiliated hospitals. He completed hematology, oncology and bone marrow transplant fellowships at the combined UCLA-Veterans Administration Program and The National Cancer Institute at the National Institutes of Health.

Jeffrey Silberberg, MD

Dr. Jeffrey Silberberg is board certified in Medical Oncology and Hematology. He has been treating patients in the Freehold area for over 22 years. Dr. Silberberg has been actively involved in clinical research as an ECOG investigator and in multiple phase 2 trials in conjunction with CINJ.